LADD Trademark

Trademark Overview

On Monday, November 9, 2015, a trademark application was filed for LADD with the United States Patent and Trademark Office. The USPTO has given the LADD trademark a serial number of 86814281. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 26, 2023. This trademark is owned by Aduro Biotech, Inc.. The LADD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services; medical research and development services in the field of treatments for cancer, infectious diseases, and immune disorders
ladd

General Information

Serial Number86814281
Word MarkLADD
Filing DateMonday, November 9, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 26, 2023
Registration Number5083914
Registration DateTuesday, November 15, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical research and development services; medical research and development services in the field of treatments for cancer, infectious diseases, and immune disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 26, 2023
Primary Code042
First Use Anywhere DateTuesday, May 27, 2014
First Use In Commerce DateTuesday, May 27, 2014

Trademark Owner History

Party NameAduro Biotech, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710
Party NameAduro Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Friday, May 26, 2023CANCELLED SEC. 8 (6-YR)
Monday, November 15, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 15, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 15, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 15, 2016REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, October 12, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 12, 2016ASSIGNED TO LIE
Tuesday, September 27, 2016NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, September 26, 2016APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Monday, September 26, 2016USE AMENDMENT ACCEPTED
Wednesday, September 7, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 6, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 24, 2016AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, August 24, 2016USE AMENDMENT FILED
Tuesday, August 23, 2016TEAS AMENDMENT OF USE RECEIVED
Wednesday, July 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2016NON-FINAL ACTION E-MAILED
Wednesday, July 13, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 13, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, July 12, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, June 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 7, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 7, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 25, 2016NON-FINAL ACTION E-MAILED
Thursday, February 25, 2016NON-FINAL ACTION WRITTEN
Monday, February 22, 2016ASSIGNED TO EXAMINER
Friday, November 13, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 12, 2015NEW APPLICATION ENTERED

Related Keywords

ladd development services research diseases immune disorders infectious field medical pharmaceutical